These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10850361)

  • 1. A new chemically modified chimeric TNT-3 monoclonal antibody directed against DNA for the radioimmunotherapy of solid tumors.
    Hornick JL; Sharifi J; Khawli LA; Hu P; Biela BH; Mizokami MM; Yun A; Taylor CR; Epstein AL
    Cancer Biother Radiopharm; 1998 Aug; 13(4):255-68. PubMed ID: 10850361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic characteristics and biodistribution of radioiodinated chimeric TNT-1, -2, and -3 monoclonal antibodies after chemical modification with biotin.
    Khawli LA; Mizokami MM; Sharifi J; Hu P; Epstein AL
    Cancer Biother Radiopharm; 2002 Aug; 17(4):359-70. PubMed ID: 12396700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chimeric TNT-3/human beta-glucuronidase fusion proteins for antibody-directed enzyme prodrug therapy (ADEPT).
    Biela BH; Khawli LA; Hu P; Epstein AL
    Cancer Biother Radiopharm; 2003 Jun; 18(3):339-53. PubMed ID: 12954121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a phage display-derived human monoclonal antibody (NHS76) counterpart to chimeric TNT-1 directed against necrotic regions of solid tumors.
    Sharifi J; Khawli LA; Hu P; King S; Epstein AL
    Hybrid Hybridomics; 2001; 20(5-6):305-12. PubMed ID: 11839248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretreatment with a monoclonal antibody/interleukin-2 fusion protein directed against DNA enhances the delivery of therapeutic molecules to solid tumors.
    Hornick JL; Khawli LA; Hu P; Sharifi J; Khanna C; Epstein AL
    Clin Cancer Res; 1999 Jan; 5(1):51-60. PubMed ID: 9918202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single amino acid substitution in the Fc region of chimeric TNT-3 antibody accelerates clearance and improves immunoscintigraphy of solid tumors.
    Hornick JL; Sharifi J; Khawli LA; Hu P; Bai WG; Alauddin MM; Mizokami MM; Epstein AL
    J Nucl Med; 2000 Feb; 41(2):355-62. PubMed ID: 10688122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting to tumor necrotic regions with biotinylated antibody and streptavidin modified liposomes.
    Pan H; Han L; Chen W; Yao M; Lu W
    J Control Release; 2008 Feb; 125(3):228-35. PubMed ID: 18022270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.
    Khawli LA; Hu P; Epstein AL
    Handb Exp Pharmacol; 2008; (181):291-328. PubMed ID: 18071951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis treatment of ME-180 human cervical carcinoma model with 131I-labeled TNT-1 monoclonal antibody.
    Chen FM; Taylor CR; Epstein AL
    Cancer Res; 1989 Aug; 49(16):4578-85. PubMed ID: 2743341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A CDR-grafted (humanized) domain-deleted antitumor antibody.
    Slavin-Chiorini DC; Kashmiri SV; Lee HS; Milenic DE; Poole DJ; Bernon E; Schlom J; Hand PH
    Cancer Biother Radiopharm; 1997 Oct; 12(5):305-16. PubMed ID: 10851481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of recombinant derivatives of chimeric TNT-3 antibody for the radioimaging of solid tumors.
    Khawli LA; Biela B; Hu P; Epstein AL
    Hybrid Hybridomics; 2003 Feb; 22(1):1-9. PubMed ID: 12713684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chimeric TNT-3 antibody/murine interferon-gamma fusion protein for the immunotherapy of solid malignancies.
    Mizokami MM; Hu P; Khawli LA; Li J; Epstein AL
    Hybrid Hybridomics; 2003 Aug; 22(4):197-207. PubMed ID: 14511565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving monoclonal antibody pharmacokinetics via chemical modification.
    Sharifi J; Khawli LA; Hornick JL; Epstein AL
    Q J Nucl Med; 1998 Dec; 42(4):242-9. PubMed ID: 9973839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stable, genetically engineered F(ab')(2) fragments of chimeric TNT-3 expressed in mammalian cells.
    Khawli LA; Biela BH; Hu P; Epstein AL
    Hybrid Hybridomics; 2002 Feb; 21(1):11-8. PubMed ID: 11991812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting strategies for cancer radiotherapy.
    Buchsbaum DJ; Rogers BE; Khazaeli MB; Mayo MS; Milenic DE; Kashmiri SV; Anderson CJ; Chappell LL; Brechbiel MW; Curiel DT
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3048s-3055s. PubMed ID: 10541342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical evaluation of chimeric L6 antibody for the treatment of Kaposi's sarcoma with radioimmunotherapy.
    Leigh BR; Burke PA; Hong AM; O'Donnell RT; Howell LP; Miers LA; DeNardo GL; DeNardo SJ
    Cancer Biother Radiopharm; 1999 Apr; 14(2):113-9. PubMed ID: 10850294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I study of 131I-chimeric(ch) TNT-1/B monoclonal antibody for the treatment of advanced colon cancer.
    Street HH; Goris ML; Fisher GA; Wessels BW; Cho C; Hernandez C; Zhu HJ; Zhang Y; Nangiana JS; Shan JS; Roberts K; Knox SJ
    Cancer Biother Radiopharm; 2006 Jun; 21(3):243-56. PubMed ID: 16918301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved tumor targeting by combined use of two antitenascin antibodies.
    Petronzelli F; Pelliccia A; Anastasi AM; D'Alessio V; Albertoni C; Rosi A; Leoni B; De Angelis C; Paganelli G; Palombo G; Dani M; Carminati P; De Santis R
    Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7137s-7145s. PubMed ID: 16203813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fully human IgG and IgM antibodies directed against the carcinoembryonic antigen (CEA) Gold 4 epitope and designed for radioimmunotherapy (RIT) of colorectal cancers.
    Garambois V; Glaussel F; Foulquier E; Ychou M; Pugnière M; Luo RX; Bezabeh B; Pèlegrin A
    BMC Cancer; 2004 Oct; 4():75. PubMed ID: 15488142
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.